Monday, 26 June 2017

Japan News

  • Eisai subsidiary announces cancer trial results

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 15 Jan, 2013

    Singapore: Eisai announced the preliminary results of its global phase III study (Study FAR 131, MORAb-003-004) of farletuzumab (MORAb-003), an investigational compound under development a...Read more

  • Positive results for Otsuka's MDR-TB treatment

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 07 Jun, 2012

    Singapore: Clinical trial results on the safety and efficacy of delamanid, Otsuka Pharmaceutical's investigational compound for the treatment of multidrug-resistant tuberculosis (MDR-TB), s...Read more

  • Naveed Shams is CEO of Santen US subsidiary

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 13 Mar, 2013

    Singapore: Japan-based Santen Pharmaceutical appointed Dr Naveed Shams as president, CEO and chief scientific officer of Santen. Prior to this new appointment, Dr Shams was VP and head of G...Read more

  • “We think India is a worthy country to expand our business”

    Japan |  Opinion | By BioSpectrum Bureau | 0 Comment | 08 Sep, 2015

    Could you briefly outline CMIC's profile and its presence in Japan? I can proudly admit that CMIC is the first Contract Research Organization in Japan. In 1992, CMIC Group pioneered the CR...Read more

  • Astellas, FHU study finds neurogenesis deficits in schizophrenics

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 26 Jul, 2012

    Singapore: A new research study has found deficits in the maturation steps of neurogenesis within the hippocampus of patients with schizophrenia or bipolar disorder. The research was conduc...Read more

  • Academia, industry team up for Japan's genomic research project

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 31 Aug, 2015

    Singapore: Led by the National Cancer Center of Japan, a joint research pact has been inked by many private companies and academic institutions to discover new drugs based on human genetic ...Read more

  • Japan approves Bayer's EYLEA Injection

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 29 Jun, 2015

    Regeneron Pharmaceuticals Inc. has announced that Bayer HealthCare's Japanese subsidiary, Bayer Yakuhin Ltd, has received approval for EYLEA (aflibercept) Injection by the Ministry of Healt...Read more

  • Japanese patent for Imugene drug delivery tech

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 05 Mar, 2013

    Singapore: Australian drug delivery technology company, Imugene, has received Japanese patent for its novel drug delivery technology Linguet. Japanese application provides protection aroun...Read more

  • Daiichi Sankyo's subsidiary launches four new generic drugs

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 18 Jun, 2015

    Daiichi Sankyo Company Limited has announced that on Friday, June 19, its generics subsidiary, Daiichi Sankyo Espha, will launch seven new generic drugs with four new active ingredients. T...Read more

  • Teikoku Pharma gets USFDA nod for non-alcohol docetaxel injection

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 04 Jan, 2016

    Singapore: Japan's Teikoku Pharma has recieved USFDA approval for Docetaxel injection, a non-alcohol formula for the treatment of breast cancer, non-small cell lung cancer, prostate cancer,...Read more

  • Sysmex gets FDA nod for XN hematology analyzers

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 24 Oct, 2012

    Singapore: Sysmex America, and Sysmex, Kobe, Japan, announced that the US FDA has cleared the Sysmex XN-Series Hematology Analyzers. Sysmex previously received a Medical Device License for...Read more

  • Netzsch acquires Bruker's thermal analyzer business in Japan

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 05 Sep, 2012

    Singapore: Netzsch Japan KK acquired Bruker Corporation's thermal analysis instruments business in Japan. Netzsch Japan will further develop, produce, distribute and service the existing an...Read more

  • Boston Scientific completes enrollment in SuperNOVA trial

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 21 Aug, 2013

    Singapore: Boston Scientific has completed enrollment in the SuperNOVA trial - a global, single arm, prospective, multicenter trial evaluating the long-term (12 month) safety and effectiven...Read more

  • mHealth apps market to reach $20.7 bn by 2018: Report

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 22 Oct, 2013

    Singapore: A recent report by Research and Markets estimates that global mHealth apps market will reach $6.6 billion in 2013 and will grow to $20.7 billion by 2018 at a CAGR of 25.50 percen...Read more

  • CSL Behring seeks Japan PMDA approval for Hemophilia drug

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 22 Dec, 2015

    Global biotherapeutics company CSL Behring has submitted its new drug application (NDA) to Japan's Pharmaceuticals and Medical Devices Agency (PMDA) for its investigational fusion protein l...Read more

  • BBK Worldwide opens Tokyo office; appoints new Managing Director

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 18 Jun, 2015

    BBK Worldwide, a leading clinical trial marketing firm, has appointed Toshio Mori to Managing Director of Operations, Japan. Mori will lead business development and help drive sales and mar...Read more

  • Gore's new endovascular therapy set to go for trials in Japan and US

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 18 Jun, 2015

    W. L. Gore & Associates, Inc. (Gore) has announced that the Food and Drug Administration (FDA) has consented to the initiation of the clinical study for the new GORE EXCLUDER Conformabl...Read more

  • Baylor Miraca Genetics appoints Gary Huff as President, CEO

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 18 Jun, 2015

    Baylor Miraca Genetics Laboratories LLC (BMGL), a joint venture company between Japan-based Miraca Holdings and Baylor College of Medicine, announced that Gary Huff will join the company as...Read more

Survey Box

Will Asia- Pacific healthcare IT market hit the double digit growth in the next five years?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls